Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase

(2010) Chia–Ming Chu et al.   Clinical Gastroenterology and Hepatology

Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia

(2010) Henry Lik-Yuen Chan   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

(2009) Dar-In Tai et al.   HEPATOLOGY

Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis

(2009) Shijian Liu et al.   JNCI-Journal of the National Cancer Institute

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

HBV A1762T, G1764A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study

(2008) Zhong-Liao Fang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

(2008) H.-I. Yang et al.   JNCI-Journal of the National Cancer Institute